Two News from Kazakhstan: Collaboration for Biotechnological Drug Production and the Best Investor Award!
At the 6th Kazakhstan Global Investment Roundtable Meeting chaired by Kazakhstan Prime Minister Alikhan Smailov, we have signed an agreement for the production of biotechnological drugs aimed at breast cancer treatment in Kazakhstan.
Through the quadripartite cooperation agreement with SK-Pharmacia LLP, a body of the Ministry of Health of Kazakhstan, the Kazakh Research Institute of Oncology and Radiology, and the Swiss pharmaceutical company Roche, we undertake the production of three biotechnological drugs for breast cancer treatment at the Nobel Almaty Pharmaceutical Factory.
In the same meeting, we were honored with the "Best Investor" award at the award ceremony for our contributions to the development of the health sector in Kazakhstan through Nobel AFF.